Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enzo Medico

Showing results (61-70 of 116) with videos related to

Pageof 12
Sort By:
Translational Oncology|June 29, 2012
High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancerLaura Annaratone, Caterina Marchiò, Tommaso Renzulli, et al.
Frontiers in Oncology|February 23, 2023
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patientErica Torchiaro, Consalvo Petti, Sabrina Arena, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2008
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responsesFederica Di Nicolantonio, Sabrina Arena, Margherita Gallicchio, et al.
Nature Communications|June 1, 2017
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancerClaudio Isella, Francesco Brundu, Sara E Bellomo, et al.
Science Translational Medicine|January 30, 2015
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapiesEugenia R Zanella, Francesco Galimi, Francesco Sassi, et al.
Cancer Research|June 29, 2012
The MET oncogene is a functional marker of a glioblastoma stem cell subtypeFrancesca De Bacco, Elena Casanova, Enzo Medico, et al.
Haematologica|August 27, 2013
STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphomaElisa Spaccarotella, Elisa Pellegrino, Manuela Ferracin, et al.
Genes, Chromosomes & Cancer|August 23, 2022
Successful treatment with MEK-inhibitor in a patient with NRAS-related cutaneous skeletal hypophosphatemia syndromeDiana Carli, Simona Cardaropoli, Daniele Tessaris, et al.
Cell Cycle (Georgetown, Tex.)|July 11, 2013
Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cellsAlessandra Pincini, Giusy Tornillo, Francesca Orso, et al.
Clinical Colorectal Cancer|April 15, 2019
A Genomic Analysis Workflow for Colorectal Cancer Precision OncologyGiorgio Corti, Alice Bartolini, Giovanni Crisafulli, et al.
Pageof 12

Showing results (61-70 of 116) with videos related to

Sort By:
Pageof 12
Translational Oncology|June 29, 2012
High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancerLaura Annaratone, Caterina Marchiò, Tommaso Renzulli, et al.
Frontiers in Oncology|February 23, 2023
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patientErica Torchiaro, Consalvo Petti, Sabrina Arena, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2008
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responsesFederica Di Nicolantonio, Sabrina Arena, Margherita Gallicchio, et al.
Nature Communications|June 1, 2017
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancerClaudio Isella, Francesco Brundu, Sara E Bellomo, et al.
Science Translational Medicine|January 30, 2015
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapiesEugenia R Zanella, Francesco Galimi, Francesco Sassi, et al.
Cancer Research|June 29, 2012
The MET oncogene is a functional marker of a glioblastoma stem cell subtypeFrancesca De Bacco, Elena Casanova, Enzo Medico, et al.
Haematologica|August 27, 2013
STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphomaElisa Spaccarotella, Elisa Pellegrino, Manuela Ferracin, et al.
Genes, Chromosomes & Cancer|August 23, 2022
Successful treatment with MEK-inhibitor in a patient with NRAS-related cutaneous skeletal hypophosphatemia syndromeDiana Carli, Simona Cardaropoli, Daniele Tessaris, et al.
Cell Cycle (Georgetown, Tex.)|July 11, 2013
Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cellsAlessandra Pincini, Giusy Tornillo, Francesca Orso, et al.
Clinical Colorectal Cancer|April 15, 2019
A Genomic Analysis Workflow for Colorectal Cancer Precision OncologyGiorgio Corti, Alice Bartolini, Giovanni Crisafulli, et al.
Pageof 12